Biodesix Inc (BDSX): Next-Year EPS Estimate 32.68%
As of 2026-11-12, Biodesix Inc (BDSX) has a next-year EPS growth estimate of 32.68%. Featured in our EPS revision report on 2026-06-29.
On 2026-11-12, analyst consensus for BDSX's next-year EPS growth shifted from 35.97% to 32.68% — a negative change of 3.29 percentage points. Current-year growth is projected at 36.74%.
What's Driving This
The primary driver is the August 6 EPS estimate upgrade for next-year growth, climbing from 40.29% to 41.54%. This was supported by Biodesix's Q2 2026 earnings call, which reported a 34% revenue surge on strong diagnostic demand. The positive revision reflects that fundamental
Generated 2026-08-14 from news as of 2026-08-14
Current Snapshot
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- EPS growth next year
- 32.68%
- EPS growth this year
- 36.74%
- EPS next quarter (est)
- -$0.69
- Last price
- $9.79
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 32.68% | 36.74% | -$0.69 | $9.79 |
| 2026-11-11 | 35.97% | 38.03% | -$0.63 | $10.12 |
| 2026-11-10 | 36.42% | 39.37% | -$0.58 | $10.02 |
| 2026-11-09 | 36.03% | 40.60% | -$0.53 | $10.34 |
| 2026-11-07 | 37.86% | 41.85% | -$0.47 | $8.53 |
| 2026-11-06 | 37.86% | 41.85% | -$0.47 | $8.53 |
| 2026-11-05 | 37.54% | 42.80% | -$0.75 | $19.84 |
| 2026-11-04 | 37.54% | 42.80% | -$0.75 | $21.49 |
| 2026-11-03 | 37.54% | 42.80% | -$0.75 | $21.05 |
| 2026-11-02 | 37.54% | 42.80% | -$0.75 | $21.78 |
| 2026-10-31 | 37.54% | 42.80% | -$0.75 | $23.25 |
| 2026-10-30 | 37.54% | 42.80% | -$0.75 | $23.25 |
| 2026-10-29 | 37.54% | 42.80% | -$0.75 | $24.72 |
| 2026-10-28 | 37.54% | 42.80% | -$0.75 | $22.86 |
| 2026-10-27 | 37.54% | 42.80% | -$0.75 | $21.95 |
| 2026-10-26 | 37.56% | 42.77% | -$0.75 | $21.26 |
| 2026-10-23 | 37.56% | 42.77% | -$0.75 | $21.18 |
| 2026-10-22 | 37.56% | 42.77% | -$0.75 | $23.94 |
| 2026-10-21 | 37.56% | 42.77% | -$0.75 | $23.93 |
| 2026-10-20 | 37.56% | 42.77% | -$0.75 | $23.87 |
| 2026-10-19 | 37.56% | 42.77% | -$0.75 | $23.40 |
| 2026-10-16 | 37.57% | 42.77% | -$0.75 | $23.66 |
| 2026-10-15 | 37.57% | 42.77% | -$0.75 | $24.71 |
| 2026-10-14 | 37.57% | 42.77% | -$0.75 | $23.99 |
| 2026-10-13 | 37.57% | 42.77% | -$0.75 | $25.00 |
| 2026-10-12 | 37.57% | 42.77% | -$0.75 | $25.70 |
| 2026-10-11 | 37.57% | 42.77% | -$0.75 | $26.02 |
| 2026-10-10 | 37.57% | 42.77% | -$0.75 | $26.02 |
| 2026-10-09 | 37.57% | 42.77% | -$0.75 | $26.02 |
| 2026-10-08 | 37.57% | 42.77% | -$0.75 | $25.63 |
Reports Featuring BDSX
Recent News
- Biodesix Breaks Its Beat-And-Raise Streak As Growth Slows To 10% And Guidance Falls Below The Original OutlookEarnings Whispers
- Biodesix Announces Third Quarter 2026 Results and HighlightsGlobeNewswire
- Biodesix Inc (BDSX) (Q2 2026) Earnings Call Highlights: Revenue Surges 34% on Strong Diagnostic ...GuruFocus.com
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Biodesix Inc's next-year EPS growth estimate?▾
As of 2026-11-12, Biodesix Inc (BDSX) has a next-year EPS growth estimate of 32.68%, based on analyst consensus.
When was the latest EPS estimate revision for BDSX?▾
The most recent revision occurred on 2026-11-12, when analysts adjusted the next-year EPS growth estimate from 35.97% to 32.68%.
What sector and industry does Biodesix Inc belong to?▾
Biodesix Inc operates in the Healthcare sector, specifically the Diagnostics & Research industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. BDSX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Biodesix Inc (BDSX) appears here because it was detected by our daily top-EPS-revision-performer screen.